• News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print
  • Editorial Calendar 19-20

Latest Articles in ranbaxy laboratories

Ex-Ranbaxy Promoter In Violation Of HC Order, Directed To Deposit 3.5 Million Singapore Dollars

Delhi High Court's order came after it learnt that Malvinder Singh, ex-promoter, Ranbaxy Laboratories sold his 45 lakh equity shares in Religare Healthcare in Singapore in April

Read More

Sun Pharma Took Two Years To Integrate Ranbaxy’s Employees

While Sun Pharmaceuticals started out the process of easing out excess employees from Ranbaxy, company also undertook several initiatives to relax and motivate the rest

Read More

Sun Pharma To Shut Some Plants In India, Overseas

Sun Pharmaceutical Industries Ltd will shut down some of its manufacturing plants in India as well as overseas as the company will continue trimming its large manufacturing base as part of cost optimisation

Read More

Court Asks Singh Brothers To Pay Rs 2,500 Crore To Daiichi

The erstwhile promoters of Ranbaxy Laboratories, the Singh brothers and family have been asked to pay damages of Rs 2,562.78 crore to Daiichi by an arbitration tribunal in Singapore for concealing and misrepresenting information during their stake sell to the Japanese firm

Read More

Sun Pharma: Acquiring Growth

Sun Pharma, promoted and led by the astute billionaire, Dilip Shanghvi, has always followed an inorganic growth strategy both in India and abroad.

Read More

Inviting Higher Risks By Challenging FDA

The industry captains allege that the FDA does not follow systems while conducting audits and follow-up actions and it doesn’t respond on time to company replies

Read More

Sun Pharma: Strong Biz Acumen

Shanghvi’s “patient approach” in fighting the odds helped Sun Pharma to scale up to the current level

Read More